The US government said Friday it has signed a preliminary agreement with semiconductor manufacturer Texas Instruments to give the company up to $1.6 billion to help fund new facilities in the country.
The proposed direct funding comes under the CHIPS and Science Act, a package of incentives passed by Congress in 2022 to boost research and US semiconductor production.
The money would give a boost to TI’s planned investment of more than $18 billion through the end of the decade to build three new facilities, the Commerce Department said in a statement.
Two of them will be in Texas and one in Utah, and they are expected to generate more than 2,000 manufacturing jobs, the department added.
The United States has been seeking to reduce reliance on China when it comes to older-generation semiconductors, amid national security concerns and as competition with Beijing intensifies.
“During the pandemic, shortages of current-generation and mature-node chips fueled inflation and made our country less safe,” Commerce Secretary Gina Raimondo said in a statement.
And Texas Instruments specializes in making such chips, which go into nearly all electronic systems.
The company’s planned projects “would meaningfully support the increasing needs for economic and national security applications,” the Commerce Department added.
The three new facilities are set to significantly boost the firm’s domestic production capacity of foundational chips.
Texas Instruments chief executive Haviv Ilan said the company plans to grow its in-house production to more than 95 percent by 2030, saying it is “building geopolitically dependable” capacity at scale.
The latest preliminary memorandum of terms also includes $10 million in proposed funding to help develop the company’s semiconductor and construction workforce, the Commerce Department said.
© 2024 AFP
Citation:
US to award chipmaker Texas Instruments up to $1.6 bn (2024, August 16)
retrieved 18 August 2024
from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.